Global Liquid Biopsy Market is expected to be US$ 3.1 Billion by 2026.

Liquid Biopsy Market

Liquid Biopsy Market

Report Description and Highlights A liquid biopsy is an emerging tool for the diagnosis of cancer disease nowadays. The liquid biopsy involves collecting samples and analysing tumours in the blood to diagnose cancer disease in the human body. Liquid biopsy assists medical practitioners as a source of genomic and proteomic knowledge in cancer patients by early detection of circulating tumour cells, DNA and extracellular vesicles.

Currently, liquid biopsy plays a critical role in accelerating and implementing accurate oncology in clinical settings by leading to an improved understanding of tumour heterogeneity and allowing for dynamic control of reactions to care and variations in genomics. According to Renub Research analysis, Global Liquid Biopsy Market is expected to be US$ 3.1 Billion by 2026.

Liquid Biopsy Market

Liquid Biopsy Market The major growth drivers of liquid biopsies are that while extracting the tissue sample from the human body is much pain-free, it substitutes the pain associated with the procedure. Besides, liquid biopsy is very accurate in detecting tumour cells in the blood of cancer patients. Due to the low sensitivity of liquid biopsy, it acts as the restraint factor in the market's growth.

The key players play an essential role in the liquid biopsy market's growth by launching innovative products. In June 2020, NeoGenomics Inc. launched three liquid biopsy tests for nonsmall cell lung cancer, solid tumour types, and specific breast cancer. The COVID-19 effect in the liquid biopsy market has been harsh because all patients are taking therapies to treat cancer; since they have a weak immune system, and they are less prone to fight with coronavirus diseases.

Request a free sample copy of the report: https://www.renub.com/requestsample-page.php?gturl=liquid-biopsy-market-p.php Liquid Biopsy Market

Liquid Biopsy Market Renub Research report titled “Liquid Biopsy Market Global Forecast by Cancer (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer & Others), Product (Kits & Consumables, Instruments and Services), Sample (Plasma/Serum, Urine & Others), Circulating Biomarkers (Circulating Tumor DNA (ctDNA), Circulating Tumor Cells (CTCs) & Exosomes), Clinical Application (Monitoring, Theranostics, Prognosis & Screening), Regions (Europe, North America, Latin America, Asia-Pacific and Middle East/Africa), Companies (Roche Diagnostics, Thermo Fisher Scientific Inc., Biocept Inc., Bio-Rad Laboratories Inc., Genomic Health, Biocartis, Myriad Genetics Inc., Qiagen, NeoGenomics Laboratories)� provides a detailed analysis of Global Liquid Biopsy Industry.

Request a free Brochure copy of the report: https://www.renub.com/requestbrochure-page.php?gturl=united-states-specialty-pharmaceuticals-market-p.php Liquid Biopsy Market

Liquid Biopsy Market

By Cancer 1.

3.

5.

Lung Cancer 2.

Colorectal Cancer4.

Others

Breast Cancer Prostate Cancer

By Product 1.

3.

Kits & Consumables Services

2.

Instruments

By Circulating Biomarkers 1.

2.

3.

4.

Circulating Tumor Cells (CTCs) Circulating Tumor DNA (ctDNA) Extracellular Vesicles Others Liquid Biopsy Market

Liquid Biopsy Market Liquid Biopsy Market Share (%) - by Regions Forecast (2021 - 2026)

Source: Renub Research Analysis

Note: These are dummy figures; actual data given in the report

Liquid Biopsy Market

Liquid Biopsy Market

By Sample 1.

3.

Plasma/Serum Others

2.

Urine

By Clinical Application 1.

3.

Monitoring Theranostics

2.

4.

Prognosis Screening

By Regions 1.

3.

5.

North America 2.

Asia-Pacific 4.

Middle East/Africa

Europe Latin America

Liquid Biopsy Market

Liquid Biopsy Market All the 9 Companies Studied in the Report have been Studied from three Points • •

Company Overview Financial Insight

•

Recent Development

By Companies 1.

2.

3.

4.

5.

6.

7.

8.

9.

Thermo Fisher Scientific Inc. Roche Diagnostics Bio-Rad Laboratories Inc. Biocept Inc. Biocartis Myriad Genetics, Inc. Genomic Health NeoGenomics Laboratories Qiagen Liquid Biopsy Market

Liquid Biopsy Market Industry Related Opportunity: China Biopsy Market is expected to reach USD 8.1 Billion by the end of the year 2026.

United States Biopsy Market is predicted to surpass USD 14 Billion by the end of the year 2025.

Global biopsy device market is anticipated to surpass USD 2.8 Billion by the year end of 2025.

United States - Liquid Biopsy Potential Testing Market & Volume Analysis to 2020

Liquid Biopsy Market

Contact Us +1-678-302-0700 (US), +91-120-421-9822 (INDIA) Visit us at: https://www.renub.com

Stay with us:

Liquid Biopsy Market